GL1X · GenesisL1 explorer

MolNFT v1 · #28692 · protein

X-ray crystallographic structure of ctx-M-9 beta-lactamase complexed with ceftazidime-like boronic acid

1YLY · Beta-lactamase ctx-M-9: “X-ray crystallographic structure of ctx-M-9 beta-lactamase complexed with ceftazidime-like boronic acid”. X-ray diffraction, 2 ligands (CB4, PO4), 2 pockets (best druggability 0.33). MolNFT v1 #28692 on…

PDB
1YLY
Type
protein
Length
523 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase ctx-M-9
EC
3.5.2.6
UniProt
Q9L5C7
Ligands
CB4, PO4
Pockets
2 · best druggability 0.33

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase ctx-M-9 (EC 3.5.2.6)protein26343% helix, 19% strandQ9L5C7
BBeta-lactamase ctx-M-9 (EC 3.5.2.6)protein26043% helix, 20% strandQ9L5C7

Ligands and binding sites

  • CB4 · Pinacol[[2-amino-alpha-(1-carboxy-1-methylethoxyimino)-4-thiazoleacetyl]amino]methaneboronate · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1760.330.7622CB4
2640.310.7618CB4

Interfaces

1 interface between chains.

  • A–B · 149 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 1YLY · X-ray crystallographic structure of CTX-M-9 beta-lactamase complexed with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.